We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Technopath Clinical Diagnostics - An LGC Company

Siemens Healthineers

Provides customized electronic systems and advanced imaging, diagnostics, therapy, and healthcare IT solutions for th... read more Featured Products: More products

Download Mobile App

Siemens Healthineers Showcases Advanced Diagnostics Analyzers

By LabMedica International staff writers
Posted on 07 Feb 2018
Print article
Image: The Atellica range was highlighted at MEDLAB 2018 (Photo courtesy of Siemens Healthineers).
Image: The Atellica range was highlighted at MEDLAB 2018 (Photo courtesy of Siemens Healthineers).
Siemens Healthineers (Erlangen, Germany) showcased its Atellica range of advanced diagnostics analyzers at MEDLAB Middle East, the world’s largest attended laboratory and IVD exhibition and conference, held from February 5-8, 2018 in Dubai, UAE.
Leading laboratory experts, scientists, researchers and clinicians converged at the three-day event to exchange and share their experiences and research results on all aspects of laboratory medicine and clinical research while companies showcased the latest innovations, products and cutting-edge technologies available in the IVD, medical laboratory and healthcare market. Among the exhibitors at the event was Siemens Healthineers, which displayed its Atellica range of flexible and scalable automation-ready immunoassay and chemistry analyzers, fully-automated high-volume coagulation system, and automated urinalysis system.
At MEDLAB Middle East 2018, Siemens exhibited its Atellica Solution, which is designed to address common clinical laboratory challenges and integrates immunoassay and clinical chemistry analyzers with the new standard in sample-management technology so laboratories can focus on driving better outcomes. Also on display was the company’s Atellica COAG 360 System, a fully automated high volume coagulation analyzer that simplifies lab operations by unifying five methodologies on one platform, streamlines hemostasis workflow through intelligent reagent and consumable management, and delivers infinite possibilities by being the first to integrate LOCI technology in specialty hemostasis testing.
Siemens also showcased the Atellica 1500 Automated Urinalysis System, which combines the CLINITEK Novus Analyzer and the new Atellica UAS 800 Analyzer. The truly digital automated urinalysis system sets new standards for accuracy and efficiency and allows laboratories to manage more samples with less staff in shorter time without compromising on high-quality results. The company also showcased the Atellica MDX 160 Molecular System, which provides innovation in the molecular laboratory by improving workflow and consolidation while providing for flexibility and customization.
Other instruments showcased by Siemens at this year’s MEDLAB Middle East included the Atellica NEPH 630 System, a mid-volume dedicated nephelometric analyzer that simplifies lab operations in specialty protein testing, and the handheld epoc Blood Analysis System which goes wherever patients are located and provides lab-quality results on the spot. Siemens also demonstrated the Atellica PM 1.0 Software, which is the only lab management system that allows the management of laboratory’s processes, including alerts, remote management of instruments, and monitoring of onboard inventory and testing progress—all from one screen.
Gold Supplier
Clinical Chemistry Reagents
SEKURE Clinical Chemistry Reagents
Microplate Reader
DP0150 Pulse 150
Automatic Hematology Analyzer

Print article


Clinical Chem.

view channel
Image: The analysis pipeline used to investigate associations between blood metabolites, later life brain imaging measures, and genetic risk for Alzheimer’s disease (Photo courtesy of University College London)

Lipid Measurements Show Potential as Alzheimer’s Disease Biomarkers

Brain changes accompanying ageing are varied and can include pathologies that lead to cognitive impairment, the commonest of which is Alzheimer’s disease (AD). Identifying blood-based signatures of brain... Read more

Molecular Diagnostics

view channel
Image: Guidance UTI provides personalized results in less than one day from receipt at lab (Photo courtesy of Pathnostics)

Rapid Result Test for Complicated Urinary Tract Infections Proves Superior to Standard Urine Culture

Complicated urinary tract infections (cUTIs) are a significant burden on individual health and healthcare resources that must be diagnosed and treated early and accurately to reduce the risk of poor outcomes.... Read more


view channel
Image: The CS-2500 analyzer features pre-analytic sample checks and four detection methods simultaneously on a single platform – coagulation end-point, chromogenic kinetic analysis, turbidimetric immunoassay and automated platelet aggregation (Photo courtesy of Sysmex)

Microvascular/Endothelial Dysfunction Contributes to Post-COVID Syndrome Pathogenesis

Post-COVID syndrome (PCS) or Long-COVID is an increasingly recognized complication of acute SARS-CoV-2 infection, characterized by persistent fatigue, reduced exercise tolerance chest pain, shortness of... Read more


view channel
Image: Sales of lateral flow assays in clinical testing are expected to register a CAGR of 5% through 2032 (Photo courtesy of Pexels)

Global Lateral Flow Assays Market to Surpass USD 11.5 Billion by 2032 Due to Evolving Applications

The global lateral flow assays market was valued at USD 7.2 billion in 2021 and is projected to register a CAGR of 4.7% during 2022-2032 to surpass USD 11.7 billion by the end of 2032, driven by the growing... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.